Nomination committee appointed for Vigmed Holding AB

In the absence of instruction from the Annual General Meeting 2015, a group of shareholders representing over 30% of the shares and votes in the Company, as of January 22, 2016, jointly together with the Board of Directors, appointed a nomination committee for the AGM 2016 and drafted a charter for its work.

The Nomination Committee consists of representatives of the three largest shareholders as of January 26, 2016, these are Henrik Blomquist (Chairman), representing Bure Equity AB (publ), Anders Spetz, representing Soliver Ltd and Mikael Karlsson as the representative of the family Karlsson (Cecilia and Amanda Karlsson).

It was further resolved that the Company's Chairman of the Board shall be a member and secretary of the committee.

The Nomination Committee is to present to the Annual General Meeting 2016 proposals for: (1) The chairman of the meeting, (2) the composition of the Board and Board members, (3) chairman and auditor(s) in the Company, and (4) their fees. The Election Committee shall represent and take all shareholders' interests into consideration.

Shareholders wishing to submit proposals to Vigmed Holding AB's Nomination Committee are welcome to do so via e-mail to: henrik.blomquist@bure.se. Or through regular mail to: Vigmed AB, Attention: Nomination Committee, Garnisonsgatan 10 , 254 66 Helsingborg, Sweden. At the latest: February 29, 2016.

________________________________

Helsingborg January 29, 2016

Vigmed Holding AB (publ)

The Nomination Committee

For further information contact:

Chairman of the board, Lennart Holm +46 70 630 8562 or CEO, Henrik Olsen +46 76 349 7364

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk of cross infections with blood-borne infectious diseases by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 500 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information about the company can be found on Vigmed’s website: www.vigmed.com/investor

Tags: